|
1）Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. 2012; 82: 270-7
|
|
|
|
2）Satoh M, Fujimoto S, Horike H, et al. Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney. Laboratory Invest. 2010; 91: 190-202
|
|
|
|
|
|
3）Satoh M, Kidokoro K, Ozeki M, et al. Angiostatin production increases in response to decreased nitric oxide in aging rat kidney. Laboratory Invest. 2013; 93: 334-43
|
|
|
|
|
|
4）Horio M, Yasuda Y, Kaimori J, et al. Performance of the Japanese GFR equation potential kidney donors. Clin Exp Nephrol. 2012; 16: 415-20
|
|
|
|
|
5）Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009; 13: 621-30
|
|
|
|
|
|
6）Berg UB. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant. 2006; 21: 2577-82
|
|
|
|
|
|
7）Chao CT, Wu VC, Lai CF, et al. Advanced age affects the outcome-predictive power of RIFLE classification in geriatric patients with acute kidney injury. Kidney Int. 2012; 82: 920-7
|
|
|
|
|
|
8）Luft FC, Grim CE, Fineberg N, et al. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation. 1979; 59: 643-50
|
|
|
|
|
|
9）Anand S, Johansen KL, Kurella Tamura M. Aging and chronic kidney disease: The impact on physical function and cognition. J Gerontol A Biol Sci Med Sci. 2013 Aug 2. [Epub ahead of print]
|
|
|
|
|
|
10）Clements ME, Chaber CJ, Ledbetter SR, et al. Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS One. 2013; 8: e70464
|
|
|
|
|
|
11）Shanahan CM. Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nature Rev Nephrol. 2013; 9: 661-70
|
|
|
|
|
|
12）Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis. 2013; 62: 339-51
|
|
|
|
|
|
13）Gambino V, De Michele G, Venezia O, et al. Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging. Aging Cell. 2013; 12: 435-45
|
|
|
|
|
|
14）Bolati D, Shimizu H, Yisireyili M, et al. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB. BMC Nephrology. 2013; 14: 56
|
|
|
|
|
|
15）Muteliefu G, Shimizu H, Enomoto A, et al. Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. Am J Physiol Cell Physiol. 2012; 303: C126-34
|
|
|
|
|
|
16）Lekawanvijit S, Kompa AR, Manabe M, et al. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS One. 2012; 7: e41281
|
|
|
|
|
|
17）Kume S, Kitada M, Kanasaki K, et al. Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch Pharm Res. 2013; 36: 230-6
|
|
|
|
|
|
18）Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390: 45-51
|
|
|
|
|
|
19）Sugiura H, Yoshida T, Shiohira S, et al. Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol. 2012; 302: F1252-64
|
|
|
|
|
|
20）Haruna Y, Kashihara N, Satoh M, et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A. 2007; 104: 2331-6
|
|
|
|
|
|
21）Nagasu H, Satoh M, Kuwabara A, et al. Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signals. Biochem Biophys Res Commun. 2011; 407: 39-43
|
|
|
|
|
|
22）Kuro-o M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol. 2013; 9: 650-60
|
|
|
|
|
|
23）Kuro-o M. Klotho in health and disease. Curr Opin Nephrol Hypertens. 2012; 21: 362-8
|
|
|
|
|
|
24）Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science (New York). 2005; 309: 1829-33
|
|
|
|
|
|
25）Liu H, Fergusson MM, Castilho RM, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science (New York). 2007; 317: 803-6
|
|
|
|
|
|
26）Satoh M, Nagasu H, Morita Y, et al. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol. 2012; 303: F1641-51
|
|
|
|
|
|
27）Doi S, Zou Y, Togao O, et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011; 286: 8655-65
|
|
|
|
|
|
28）Leunissen EH, Nair AV, Bull C, et al. The epithelial calcium channel TRPV5 is regulated differentially by Klotho and sialidase. J Biol Chem. 2013; 288: 29238-46
|
|
|
|
|
|
29）Huang CL. Regulation of ion channels by secreted Klotho. Adv Exp Med Biol. 2012; 728: 100-6
|
|
|
|
|
|
30）Voelkl J, Alesutan I, Leibrock CB, et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest. 2013; 123: 812-22
|
|
|
|
|
|
31）Hu MC, Kuro-o M, Moe OW. Klotho and chronic kidney disease. Contrib Nephrol. 2013; 180: 47-63
|
|
|
|
|
|
32）Sun CY, Chang SC, Wu MS. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int. 2012; 81: 640-50
|
|
|
|
|